EXACT SCIENCES CORP Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount
EXACT SCIENCES CORP reported Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Notes › Investments › Equity Securities without Readily Determinable Fair Value, Annual Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount · last filed 2024-05-08
- EXACT SCIENCES CORP equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- EXACT SCIENCES CORP equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2023-03-31 was $400.00K.
- EXACT SCIENCES CORP equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2023 was $4.25M, a 60.72% decline from fiscal 2022.
- EXACT SCIENCES CORP equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2022 was $10.82M.
| Period end | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 12 month |
|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $4.25M 10-K · filed 2024-02-21 | |
| 2023-03-31 | $400.00K 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $10.82M 10-K · filed 2024-02-21 |